Cargando…

Selection of Nanobodies that Target Human Neonatal Fc Receptor

FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, Jan Terje, Gonzalez-Pajuelo, Maria, Foss, Stian, Landsverk, Ole J. B., Pinto, Débora, Szyroki, Alexander, de Haard, Hans J., Saunders, Michael, Vanlandschoot, Peter, Sandlie, Inger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552320/ https://www.ncbi.nlm.nih.gov/pubmed/23346375 http://dx.doi.org/10.1038/srep01118

Ejemplares similares

TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity
por: Foss, Stian, et al.
Publicado: (2015)

The Neonatal Fc Receptor (FcRn): A Misnomer?
por: Pyzik, Michal, et al.
Publicado: (2019)

Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life
por: Andersen, Jan Terje, et al.
Publicado: (2012)

Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
por: Gjølberg, Torleif Tollefsrud, et al.
Publicado: (2022)

Human and mouse albumin bind their respective neonatal Fc receptors differently
por: Nilsen, Jeannette, et al.
Publicado: (2018)

TRIM21—From Intracellular Immunity to Therapy
por: Foss, Stian, et al.
Publicado: (2019)

A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
por: Grevys, Algirdas, et al.
Publicado: (2018)

Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?
por: Zakrzewicz, Anna, et al.
Publicado: (2022)

Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
por: Andersen, Jan Terje, et al.
Publicado: (2012)

Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942
por: Zakrzewicz, Anna, et al.
Publicado: (2022)

Antibody-antigen kinetics constrain intracellular humoral immunity
por: Bottermann, Maria, et al.
Publicado: (2016)

Corrigendum: Antibody-antigen kinetics constrain intracellular humoral immunity
por: Bottermann, Maria, et al.
Publicado: (2017)

Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics
por: Sand, Kine Marita Knudsen, et al.
Publicado: (2015)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex–driven autoimmunity
por: Hubbard, Jonathan J., et al.
Publicado: (2020)

Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties
por: Sivertsen, Magne Sand, et al.
Publicado: (2018)

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo
por: Mester, Simone, et al.
Publicado: (2021)

Polymeric human Fc-fusion proteins with modified effector functions
por: Mekhaiel, David N. A., et al.
Publicado: (2011)

VHH selected against the viral spike protein can protect mice against lethal rabies virus challenge
por: Rosseels, Valérie, et al.
Publicado: (2011)

Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
por: Czajkowsky, Daniel M., et al.
Publicado: (2015)

Synthetic nanobodies as tools to distinguish IgG Fc glycoforms
por: Kao, Kevin S., et al.
Publicado: (2022)

Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
por: Grevys, Algirdas, et al.
Publicado: (2022)

Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity
por: Andersen, Aram Nikolai, et al.
Publicado: (2016)

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
por: Stapleton, Nigel M., et al.
Publicado: (2011)

Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies
por: Hong, Haofei, et al.
Publicado: (2019)

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
por: Hultberg, Anna, et al.
Publicado: (2011)

Delivery of an anti‐transthyretin Nanobody to the brain through intranasal administration reveals transthyretin expression and secretion by motor neurons
por: Gomes, João R., et al.
Publicado: (2018)

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody
por: Mørtberg, Trude V., et al.
Publicado: (2022)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

Complement C4 Prevents Viral Infection through Capsid Inactivation
por: Bottermann, Maria, et al.
Publicado: (2019)

Binding to Nanopatterned Antigens is Dominated by the Spatial Tolerance of Antibodies
por: Shaw, Alan, et al.
Publicado: (2019)

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
por: Serrano-Rivero, Yunier, et al.
Publicado: (2023)

Site-specific (68)Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
por: Dewulf, Jonatan, et al.
Publicado: (2023)

Novel application of anti‐human Fc nanobody for screening high‐producing CHO cells for monoclonal antibody
por: Zhu, Di, et al.
Publicado: (2022)

Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide–MHC Interactions
por: Løset, Geir Åge, et al.
Publicado: (2015)

Escherichia coli surface display for the selection of nanobodies
por: Salema, Valencio, et al.
Publicado: (2017)

Expanding the Versatility of Phage Display II: Improved Affinity Selection of Folded Domains on Protein VII and IX of the Filamentous Phage
por: Løset, Geir Åge, et al.
Publicado: (2011)

The therapeutic age of the neonatal Fc receptor
por: Pyzik, Michal, et al.
Publicado: (2023)

The neonatal Fc receptor is expressed by human lymphocytes
por: van Bilsen, K, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5gebh00vsfb81fddg3s7flib7q